Table 3.
Obstetric outcomes between two group
| Variables | Control group (n = 48) |
rhTPO group (n = 33) |
Statistical value | P |
|---|---|---|---|---|
| Gestational weeks of delivery (weeks) | 37.1 (37, 37.2) | 37.6 (37, 38.4) | -3.356a | 0.001 |
| Mode of delivery | 1.591b | 0.207 | ||
| Vaginal delivery, n (%) | 10 (20.8) | 11 (33.3) | ||
| Cesarean section, n (%) | 38 (79.2) | 22 (66.7) | ||
| Postpartum hemorrhage, n (%) | 0.188b | 0.665 | ||
| No | 41 (85.4) | 27 (81.8) | ||
| Yes | 7 (14.6) | 6 (18.2) | ||
| Postpartum hemorrhage (ml) | 500 (400, 800) | 500 (234, 680) | -0.697a | 0.486 |
| Fetal or neonatal complications, n (%) | 0.313b | 0.576 | ||
| No | 32 (66.7) | 20 (60.6) | ||
| Yes | 16 (33.3) | 13 (39.4) | ||
| Premature, n (%) | 0.031b | 0.859 | ||
| No | 40 (83.3) | 27 (81.8) | ||
| Yes | 8 (16.7) | 6 (18.2) | ||
| Low birth weight (< 2.5 kg), n (%) | 0.405b | 0.524 | ||
| No | 43 (89.6) | 28 (84.8) | ||
| Yes | 5 (10.4) | 5 (15.2) | ||
| Neonatal platelets < 100 × 109/L, n (%) | 0.100b | 0.752 | ||
| No | 35 (72.9) | 23 (69.7) | ||
| Yes | 13 (27.1) | 10 (30.3) | ||
| Apgar score≦7 at 1 min, n (%) | NA | 0.511c | ||
| No | 46 (95.8) | 33 (100) | ||
| Yes | 2 (4.2) | 0 (0) | ||
| Neonatal platelets on day 1(× 109/L) | 150 (106.8, 181) | 123 (90.5, 156) | -1.558a | 0.119 |
| Neonatal platelets on day 3(× 109/L) | 151 (87.8, 188) | 121 (72, 162) | -1.761a | 0.078 |
| Neonatal platelets on day 5(× 109/L) | 170 (107.5, 204) | 165 (113, 183) | -1.077a | 0.282 |
Postpartum hemorrhage was defined as a blood loss of ≥ 500 ml from the genital tract for vaginal deliveries and ≥ 1000 ml for caesarean sections, within 24 h of delivery
Fetal or neonatal complications: including premature, low birth weight, neonatal platelets < 100 × 109/L, Apgar score≦7 at 1 min, fetal malformations, stillbirth and neonatal death
Abbreviations: NA not applicable
aMann-Whitney U Test
bChi-square test
cFisher exact probability test